Document Classification

Section Type: RESULTS

Text: No significant differences in rates of mortality (placebo, n = 6, 46 %, 90 % confidence interval (CI) : 22 % to 71 % ; rFVIIa, n = 5, 29 %, 90 % CI : 12 % to 56 % ; P = 0. 19), in median numbers of intensive care unit-free days (placebo = 0, rFVIIa = 3 ; P = 0. 26) or ventilator-free days (placebo = 0, rFVIIa = 10 ; P = 0. 19), or in rates of thromboembolic adverse events (placebo, 15 %, 90 % CI : 3 % to 51 % ; rFVIIa, 0 %, 90 % CI : 0 % to 53 % ; P = 0. 18) or serious adverse events (placebo, 92 %, 90 % CI : 68 % to 98 % ; rFVIIa, 82 %, 90 % CI : 60 % to 92 % ; P = 0. 61) were observed between treatment groups.